BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/29/2016 11:06:00 AM | Browse: 1139 | Download: 2166
 |
Received |
|
2015-06-24 09:18 |
|
Peer-Review Started |
|
2015-06-24 10:56 |
|
To Make the First Decision |
|
2015-07-28 10:50 |
|
Return for Revision |
|
2015-08-03 16:47 |
|
Revised |
|
2015-09-09 11:30 |
|
Second Decision |
|
2015-11-02 14:33 |
|
Accepted by Journal Editor-in-Chief |
|
2015-11-05 23:15 |
|
Accepted by Executive Editor-in-Chief |
|
2015-11-17 09:17 |
|
Articles in Press |
|
2015-11-17 09:17 |
 |
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2016-01-19 20:24 |
|
Publish the Manuscript Online |
|
2016-01-29 11:06 |
| ISSN |
2150-5349 (online) |
| Open Access |
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
|
| Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Hepatitis C virus: A time for decisions. Who should be treated and when?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Bashar M Attar and David H Van Thiel |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Bashar M Attar, MD, PhD, MPH, Cook County Health and Hospitals System, Rush University Medical Center, 1901 West Harrison Street, Chicago, IL 60612,
United States. battar@rush.edu
|
| Key Words |
Hepatitis C virus; Direct acting antivirals; Cirrhosis of the liver; Timing of treatment |
| Core Tip |
This study presents the burden of hepatitis C virus (HCV) infection. Current guidelines limit treatment to those with advanced liver disease (Metavir F-3 or F-4 fibrosis). This represents a small fraction of those infected having the worse prognosis. They are unlikely to infect others. In contrast, the much larger group F-0 to F-2 is the vectors for additional infections. The plague of HCV can only be eliminated if the larger groups that infect others are treated. The cost of treating this larger population is expensive but much less expensive than treating only those with advanced fibrosis in the long run.
|
| Publish Date |
2016-01-29 11:06 |
| Citation |
Attar BM, Van Thiel DH. Hepatitis C virus: A time for decisions. Who should be treated and when? World J Gastrointest Pharmacol Ther 2016; 7(1): 33-40 |
| URL |
http://www.wjgnet.com/2150-5349/full/v7/i1/33.htm |
| DOI |
http://dx.doi.org/10.4292/wjgpt.v7.i1.33 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
